NK cells and γδ+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis

被引:56
作者
Katsuta, Michie
Takigawa, Yukio
Kimishima, Momoko
Inaoka, Miyuki
Takahashi, Ryo
Shiohara, Tetsuo
机构
[1] Kyorin Univ, Sch Med, Dept Dermatol, Mitaka, Tokyo 1818611, Japan
[2] Kyorin Univ, Sch Med, Div Flow Cytometry, Mitaka, Tokyo 1818611, Japan
关键词
D O I
10.4049/jimmunol.176.12.7736
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Innate immune cells mediate a first line of defense against pathogens and determine the nature of subsequent acquired immune responses, mainly by producing profound amounts of cytokines. Given these diverse tasks, it is predictable that defective NK and gamma delta(+) T cell responses could be the underlying mechanism for the immunological alterations observed in atopic dermatitis (AD). Indeed, the frequencies of circulating NK cells and gamma delta(+) T cells were profoundly reduced in AD patients. They also displayed a defective ability to sustain TNF-alpha and IFN-gamma, but not IL-4, production after in vitro stimulation, and the defect was restricted to innate immune cells. Surprisingly, on the depletion of CD14(+) monocytes, this selective impairment of TNF-alpha and IFN-gamma production was restored to levels comparable to that observed in controls. Release of IL-10 from monocytes was not a major mechanism of the NK and gamma delta(+) T cell dysfunction. Apoptosis as revealed by annexin V binding, was preferentially observed in NK and gamma delta(+) T cells from AD patients when stimulated in the presence of monocytes, and depletion of monocytes significantly protected these cells from apoptotic cell death. Preferential apoptosis of NK cells by activated monocytes in AD patients was cell-contact-dependent. These results indicate that, once NK and gamma delta(+) T cells in AD patients are in immediate contact with activated monocytes, these cells are specifically targeted for apoptosis, leading to the reduced type 1 cytokine production, thereby directing subsequent acquired immune responses toward a type-2 pattern and increasing susceptibility to infection.
引用
收藏
页码:7736 / 7744
页数:9
相关论文
共 29 条
[1]   Immunological differences between intrinsic and extrinsic types of atopic dermatitis [J].
Akdis, CA ;
Akdis, M .
CLINICAL AND EXPERIMENTAL ALLERGY, 2003, 33 (12) :1618-1621
[2]  
Battistini L, 1997, J IMMUNOL, V159, P3723
[3]   Natural killer cells in antiviral defense: Function and regulation by innate cytokines [J].
Biron, CA ;
Nguyen, KB ;
Pien, GC ;
Cousens, LP ;
Salazar-Mather, TP .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :189-220
[4]   No modulation of circulating natural killer cell and natural killer receptor bearing memory T cell subsets in patients with atopic dermatitis [J].
Bouloc, A ;
Charue, D ;
Nikolova, M ;
Bensussan, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (06) :1160-1162
[5]   Potential role for interleukin-15 in the regulation of human natural killer cell survival [J].
Carson, WE ;
Fehniger, TA ;
Haldar, S ;
Eckhert, K ;
Lindemann, MJ ;
Lai, CF ;
Croce, CM ;
Baumann, H ;
Caligiuri, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) :937-943
[6]   INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR [J].
CARSON, WE ;
GIRI, JG ;
LINDEMANN, MJ ;
LINETT, ML ;
AHDIEH, M ;
PAXTON, R ;
ANDERSON, D ;
EISENMANN, J ;
GRABSTEIN, K ;
CALIGIURI, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1395-1403
[7]   CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation [J].
Dalbeth, N ;
Gundle, R ;
Davies, RJO ;
Lee, YCG ;
McMichael, AJ ;
Callan, MFC .
JOURNAL OF IMMUNOLOGY, 2004, 173 (10) :6418-6426
[8]   Natural killer cells and viral infections [J].
French, AR ;
Yokoyama, WM .
CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (01) :45-51
[9]   Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells:: A regulatory role of monocytes and IL-10 [J].
Goodier, MR ;
Londei, M .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :139-147
[10]  
HALL TJ, 1985, IMMUNOLOGY, V56, P337